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Abstract 
While serum is frequently used in biomarker discovery, most of its total protein content is 
dominated by a small number of proteins, masking the presence of low abundance 
proteins, which may be candidate biomarkers of disease.  Therefore, a serum depletion 
strategy is commonly implemented in order to remove abundant proteins, thereby 
increasing the number of proteins detected. Antibody-based Spin Columns offer a 
straightforward and cost-effective methodology of serum depletion.  The Seppro
® 
IgY 
Spin Columns used in this study bind 12 and 14 primate proteins respectively. 1D SDS 
PAGE and 2DE revealed a sub-optimal performance of the IgY Spin Columns. However, 
modification of the manufacturer’s protocol; subjecting samples to two rounds of 
depletion, improved the number of proteins resolved by 2DE. Importantly, 2DE and 
MALDI-MS analysis revealed that no non-target proteins were removed from the human 
serum samples.  With alteration of the manufacturer protocol the Seppro
®
 IgY14 Spin 
Column can produce depleted serum with an increased number of spots resolved by 2DE 
compared to untreated serum.  
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Serum and plasma are commonly used in biomarker discovery studies [1]. However, a 
small number of proteins, such as albumin, dominate a large portion of the total protein 
content [2, 3]. The presence of these highly abundant proteins can mask the presence of 
lower abundance proteins among which are candidate biomarkers of disease.  Therefore, 
the use of a serum depletion strategy to remove these abundant proteins is commonly 
employed [4-7].   
 Antibody-based depletion technologies present a method of depleting biofluids of 
abundant proteins in a specific manner.  The Seppro
®
 IgY system (Sigma) is used in this 
study. IgY antibodies are avian and display reduced non-specific binding compared with 
IgG antibodies [8]. IgY proteome partitioning technology was developed by Genway to 
remove 12 primate proteins from biofluids and the system has been subsequently 
developed to remove a further 2 proteins.  This study aimed to assess the efficiency of 
depletion of abundant proteins from human serum by IgY Spin Column technology using 
1D SDS PAGE, 2DE and MALDI-MS. 
Abundant proteins were removed from healthy human serum using the Beckman Coulter 
IgY12 Spin Column (Phenomenexx).  This contains IgY antibodies against albumin, IgG, 
fibrinogen, transferrin, IgA, IgM, apolipoprotein A-I and II, haptoglobin, α1 antitrypsin, 
α1 acidglycoprotein, and α2 macroglobulin.  The Seppro® IgY14 Spin Column (Sigma) 
was also used.  This removes two further proteins; apolipoprotein B and complement C3. 
20μL serum was diluted with Dilution Buffer (supplied with columns) and filtered using 
Costar Spin-X centrifuge tubes 0.45µm pore size (Sigma). Serum was applied to the spin 
column and incubated for 15 minutes.  Depleted serum was eluted by centrifugation for 
30 seconds at 2,000 g. Depleted serum was acetone precipitated in 4 volumes of ice-cold 
acetone overnight at -20
o
C. Spin Columns were then washed 3 times with Dilution 
Buffer.  Abundant proteins were stripped from the Spin Columns by 4 steps of incubation 
in Stripping Buffer (supplied), followed by centrifugation for a total of no more than 15 
minutes.  Spin Columns were then immediately regenerated with Neutralising Buffer 
(supplied), incubated for 5 minutes followed by centrifugation. Samples were 
resuspended in sample buffer (9.5 M Urea; USB 2% CHAPS; USB, 0.8% Pharmalyte; 
GE Healthcare, 1% DTT; USB).  1D SDS PAGE was carried out on 4% acrylamide 
stacking gel, 10% acrylamide resolving gel using Laemmlli sample buffer (Sigma) and 
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run under 20mA current per gel in Laemmlli buffer. For 2DE, protein was passively 
rehydrated on IPG strips (GE Healthcare) pH interval 4-7 overnight. IEF was carried out 
for 9 kVolt hours (7cm IPG strips) or 80 kVolt hours (24cm IPG strips).  IPG strips were 
equilibrated for SDS PAGE in 2 steps, 15 minutes each, using 6M urea (USB), 50 mM 
Tris HCl pH 8.8, 30% (v/v) glycerol (USB), 2% (w/v) SDS (USB) and adding 1% (w/v) 
DTT (USB) for the first equilibration and 2.5 % (w/v) iodoacetamide (USB) for the 
second equilibration.  IPG strips were applied to 12% acrylamide gels and run at 20mA 
per gel (10x8 cm gels) or 1W per gel (24x20 cm gels) using Laemmlli buffer. Gels were 
stained with either Plus One Silver (GE Healthcare) or Coomassie (Invitrogen).  Gels 
were scanned using the Biorad GS-800 Calibrated Densitometer scanner and analysed 
using Quantity One software. Coomassie stained 1D SDS PAGE bands were digested 
overnight with trypsin (Promega). MALDI-TOF and MALDI-TOF/TOF mass 
spectrometric analyses were carried out with a 4800 plus MALDI TOF/TOF Analyzer 
(Applied Biosystems).  Peptide masses were acquired over a range from 800 to 4000 m/z, 
with a focus mass of 2000 m/z. MS spectra were summed from 2500 laser shots from an 
Nd: YAG laser operating at 355 nm and 200 Hz. An automated plate calibration was 
performed using five peptide standards (masses 900-2400 m/z; Applied Biosystems) in 
thirteen calibration wells. This plate calibration was used to update the instrument default 
mass calibration, which was applied to all MS and MS/MS spectra. A maximum of 12 
precursors per sample well with a signal-to-noise ratio of >20 was automatically selected 
for subsequent fragmentation by collision induced dissociation. MS/MS spectra were 
summed from 4000 laser shots. Spectra were processed and analyzed by the Global 
Protein Server Workstation (Version 3.6, Applied Biosystems). This uses internally 
licensed MASCOT (Matrix Science) software for matching MS and MS/MS data against 
in silico protein digest databases. The MASCOT search parameters were set to run an all 
entries search against a UniProt knowledgebase (release 14.0, containing 392,667 entries) 
downloaded from the European Bioinformatics Institute homepage 
(http://ftp.ebi.ac.uk/pub/databases); allowing a single missed cleavage, two variable post-
translational modifications (methionine oxidation and carbamidomethylation), a 
precursor tolerance of 100 ppm and MS/MS tolerance of 0.25 Da, and peptide charge of 
+1. Peptides were filtered for subsequent identification and analysis allowing a maximum 
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of top 10 ranked peptides using the Mowse scoring algorithm which calculates protein 
identification probability. A human specific database was filtered out from this UniProt 
knowledgebase.  
Initial results following the manufacturer’s instructions for both columns showed sub-
optimal depletion (Figure 1A Lane 3, Figure 1E Lane 2).  Further, the binding efficiency 
of the IgY12 Spin Column deteriorated over time (Figure 1B).  To demonstrate that the 
IgY antibodies were saturated with bound protein we performed several cycles where no 
sample was applied to the IgY12 Columns.  Figure 1C points to incomplete removal of 
protein from the Spin Column during the stripping phase of the previous depletion cycles 
(Lanes 1-4).   Serum sample treated twice by IgY12 Spin Column (Figure 1D) shows 
reduced band of protein at the molecular weight of albumin compared with the same 
sample treated once. Reducing the starting volume of serum improves depletion using the 
IgY14 Spin Column (Figure 1E), however, 20µL depleted twice sample (Lane 6) shows 
the best depletion of abundant proteins. Initial 2DE experiments were carried out utilising 
7cm IPG strips and mini gels; due to the low capacity of the IgY Spin Columns. A second 
application of a depleted 20µL sample to the column reveals a significantly different 2DE 
image (Figure 2A), indicative of the further removal of abundant proteins during the 
second cycle of depletion.  A similar trend is observed using the IgY14 Spin Column in 
2DE (Figure 2B).  Further, resolution of higher molecular weight proteins is enhanced in 
the twice depleted sample compared with a single depletion. These results indicate that a 
reduction in the recommended starting volume of human serum produces an 
improvement in the resolution of proteins detected by 2DE.  Moreover, treating serum 
samples twice provided further improvement in resolution of spots by 2DE. To assess 
non-specific removal of proteins by the IgY Spin Columns the bound fractions of both 
Spin Columns were analysed.  Figures 2C and 2D show clean capture of abundant 
proteins and no removal of non-target proteins. MALDI-MS was used to confirm the 
identities of proteins bound by both IgY Spin Columns.    No non-target proteins were 
identified by MALDI-MS (Table 1).  
Spin Column technologies offer a relatively inexpensive and straightforward 
methodology for the removal of abundant proteins from biofluids.  However, this study 
highlights insufficiencies with two generations of IgY Spin Columns.  1D SDS PAGE 
8 
 
and 2DE demonstrate that when following the supplied protocol, while there is a 
reduction in abundant proteins; albumin is visible in 20µL treated once by both IgY12 
and IgY14 columns (Figure 1A Lane 3 and Figure 2B Lane 2).  As the columns purport 
to remove a number of proteins, this inadequate removal of albumin is taken as indicative 
of overall sub-optimal performance of the column.  Further, depletion deteriorated over 
time (Figure 1B) and significant amounts of albumin were eluted on cycles where no 
sample was loaded (Figure 1C). These issues were addressed with the re-application of 
eluted serum to further remove abundant proteins (Figure 1A Lane 2, Figure 1B Lane 6) 
and by the use of ‘buffer only’ cycles between samples to eradicate any bound protein not 
removed during the stripping phase of the depletion cycle.  Optimization of the protocol 
produced much improved results by 1D SDS PAGE and 2DE (Figures 1 and 2). In Figure 
2 mini-gel 2DE images are placed in parallel with large 2DE gel images.  These initial 
mini-gels were carried out as the amount of protein eluted in the depleted serum fraction 
was relatively small.  Figure 2A and 2B are intended as an illustration of a similar trend 
between the two columns.  Both 2DE and MALDI-MS analyses of the human serum 
proteins bound by both columns revealed no non-target proteins. However, previous 
serum depletion studies have reported the removal of non-target proteins [9-11]. This 
study demonstrates that, with some alteration to the given protocol, suitably depleted 
serum can be produced by IgY Spin Columns in the context of a biomarker study.   
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Figure 1. Arrows indicates band at molecular weight of albumin.  A. 1D SDS PAGE of 
crude serum, proteins bound, and depleted serum eluted from the IgY12 Spin Column.  
Starting volume of serum was 20μL.  40μg protein was loaded in each lane. B. 1D SDS 
PAGE of crude serum and serum eluted from the IgY12 Spin Column after 50 uses (A 
and B Coomassie stained (Invitrogen)). C. 1D SDS PAGE of protein eluted from IgY12 
Spin Column following ‘buffer only’ runs.  Band shown is consistent with the molecular 
weight of albumin.  C1=Spin Column 1 C2=Spin Column 2. (Silver stained (GE 
Healthcare)). D. 1D SDS PAGE of serum eluted from IgY12 Spin Column. 20µL serum 
was treated once and 20µL of an identical sample was treated twice.  E. 1D SDS PAGE 
showing the effect of varying starting volume of serum using the IgY14 Spin Column.  
Lane 6 20 µL depleted twice shows the best depletion of abundant proteins. 10µg protein. 
(D and E Coomassie stained).  
Figure 2. Silver stained 2DE of human serum samples following depletion by IgY Spin 
Columns. A. IgY12 treated samples; 10ug protein loaded on each gel, IPG strips pH 4-7 
7cm. B. IgY14 Spin Column treated samples; 50μg protein loaded onto 24 cm IPG strips 
pH 4-7. LC=Light Chain. 2DE gel analysis of the bound protein from the IgY12 Spin 
Column (C) and the IgY14 Spin Column (D).  Human serum was applied to the IgY Spin 
Columns, bound proteins stripped from the column and subject to 2DE, 24cm IPG strips 
ph4-7 and silver stained.  Proteins were identified by eye through comparison with the 
2DE of human plasma available on SWISS-2DPAGE Viewer on the ExPASy Proteomics 
Server.  http://expasy.org/swiss-2dpage/viewer HC=Heavy Chain 
Table 1. MALDI-MS results identifying proteins bound by IgY Spin Columns when 
human serum was applied, and the bound proteins subsequently stripped from the 
column.  The bound proteins were subject to 1D SDS PAGE, Coomassie stained, bands 
of protein excised, trypsin digested and analysed by MALDI-MS.  Table shows 
identifications with a confidence interval of >99%.  A. IgY14 Spin Column: 7 proteins 
were identified by MALDI-MS, plus Ig kappa chain which may belong to the light chain 
of IgG (identified), IgM (identified) or IgA (not identified).   B. IgY12 Spin Column: 9 
proteins of the 12 listed were identified.  Of the proteins not identified, fibrinogen was 
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not expected to be identified as it is present in plasma but not serum.*UniProtKB 
accession number 
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Figure 1. 
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Figure 2. 
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